Birdwatch Note
2024-11-01 05:05:27 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
インフルエンザワクチンが、重症化を防ぐという事には何の根拠もないという本投稿の主張ですが、 インフルエンザの試験条件における入院予防効果は昨年の最新のランダム化比較試験のメタ解析でも認められている事に注意が必要です。 https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(22)00061-X/fulltext 下記のpdfの106ページがサマリーになります(ワクチンの種類にもよりますが概ねプラセボ比で有意差をもって有効性を示しています)。 https://www.thelancet.com/cms/10.1016/j.eclinm.2022.101331/attachment/add05858-632f-4d0a-8024-c51062b9b51b/mmc1.pdf#page=106 またワクチンで使われる抗菌作用のある微量の水銀化合物は2009年にもPMDAの安全対策調査委員会のレビューが行われ因果関係を示す根拠がないと結論されています。 https://www.mhlw.go.jp/shingi/2009/10/dl/s1018-2f.pdf
Written by F4D2E4CA66E08B99BDDE8328BBF4C2313B853B3595C8AC38600E463328C72D9D
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1852157951940935712
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1852215352232677800
- noteId - 1852215352232677800
- participantId -
- noteAuthorParticipantId - F4D2E4CA66E08B99BDDE8328BBF4C2313B853B3595C8AC38600E463328C72D9D Participant Details
- createdAtMillis - 1730437527126
- tweetId - 1852157951940935712
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 1
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- インフルエンザワクチンが、重症化を防ぐという事には何の根拠もないという本投稿の主張ですが、 インフルエンザの試験条件における入院予防効果は昨年の最新のランダム化比較試験のメタ解析でも認められている事に注意が必要です。 https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(22)00061-X/fulltext 下記のpdfの106ページがサマリーになります(ワクチンの種類にもよりますが概ねプラセボ比で有意差をもって有効性を示しています)。 https://www.thelancet.com/cms/10.1016/j.eclinm.2022.101331/attachment/add05858-632f-4d0a-8024-c51062b9b51b/mmc1.pdf#page=106 またワクチンで使われる抗菌作用のある微量の水銀化合物は2009年にもPMDAの安全対策調査委員会のレビューが行われ因果関係を示す根拠がないと結論されています。 https://www.mhlw.go.jp/shingi/2009/10/dl/s1018-2f.pdf
Note Ratings
rated at | rated by | |
2024-11-01 07:12:42 -0500 | Rating Details | |
2024-11-01 05:10:44 -0500 | Rating Details | |
2024-11-01 05:01:15 -0500 | Rating Details | |
2024-11-01 04:39:25 -0500 | Rating Details | |
2024-11-01 04:20:11 -0500 | Rating Details | |
2024-11-01 04:13:51 -0500 | Rating Details | |
2024-11-01 02:58:39 -0500 | Rating Details | |
2024-11-01 02:50:29 -0500 | Rating Details | |
2024-11-01 02:39:35 -0500 | Rating Details | |
2024-11-01 01:40:50 -0500 | Rating Details | |
2024-11-01 00:58:40 -0500 | Rating Details | |
2024-11-01 00:44:00 -0500 | Rating Details | |
2024-11-01 00:35:58 -0500 | Rating Details | |
2024-11-01 00:22:20 -0500 | Rating Details | |
2024-11-02 02:45:51 -0500 | Rating Details | |
2024-11-01 09:52:14 -0500 | Rating Details | |
2024-11-01 05:01:14 -0500 | Rating Details | |
2024-11-01 03:22:52 -0500 | Rating Details | |
2024-11-01 03:03:49 -0500 | Rating Details | |
2024-11-01 02:04:04 -0500 | Rating Details | |
2024-11-01 01:23:25 -0500 | Rating Details | |
2024-11-02 09:54:04 -0500 | Rating Details | |
2024-11-01 11:49:38 -0500 | Rating Details | |
2024-11-01 07:24:48 -0500 | Rating Details | |
2024-11-01 03:39:22 -0500 | Rating Details | |
2024-11-01 02:26:44 -0500 | Rating Details | |
2024-11-01 01:32:41 -0500 | Rating Details | |
2024-11-01 01:31:57 -0500 | Rating Details | |
2024-11-01 01:24:43 -0500 | Rating Details | |
2024-11-01 00:44:34 -0500 | Rating Details | |
2024-11-01 00:21:48 -0500 | Rating Details | |
2024-11-01 00:11:33 -0500 | Rating Details | |
2024-11-02 02:13:00 -0500 | Rating Details | |
2024-11-01 11:31:26 -0500 | Rating Details | |
2024-11-01 04:55:55 -0500 | Rating Details | |
2024-11-01 03:45:43 -0500 | Rating Details | |
2024-11-01 03:41:20 -0500 | Rating Details | |
2024-11-01 03:40:45 -0500 | Rating Details | |
2024-11-01 02:46:16 -0500 | Rating Details | |
2024-11-01 01:55:26 -0500 | Rating Details | |
2024-11-01 01:13:20 -0500 | Rating Details | |
2024-11-01 01:09:24 -0500 | Rating Details | |
2024-11-01 01:07:06 -0500 | Rating Details | |
2024-11-01 00:48:24 -0500 | Rating Details | |
2024-11-01 00:45:30 -0500 | Rating Details | |
2024-11-01 00:20:54 -0500 | Rating Details | |
2024-11-10 19:37:51 -0600 | Rating Details | |
2024-11-01 16:27:02 -0500 | Rating Details | |
2024-11-01 06:58:15 -0500 | Rating Details | |
2024-11-01 06:48:47 -0500 | Rating Details | |
2024-11-01 03:39:29 -0500 | Rating Details | |
2024-11-01 02:41:01 -0500 | Rating Details | |
2024-11-01 02:04:33 -0500 | Rating Details | |
2024-11-01 01:21:10 -0500 | Rating Details | |
2024-11-01 00:17:31 -0500 | Rating Details |